Home › Cancro ovarico › Ohio › Dayton
Studi clinici su Cancro ovarico a Dayton, OH
9 studi su Cancro ovarico cercano partecipanti presso sedi a Dayton e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
In reclutamentoFase 2
- Miami Valley Hospital, Dayton
- Premier Blood and Cancer Center, Dayton
- Miami Valley Hospital North, Dayton
- e altri 5
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
In reclutamentoFase 2
- Kettering Medical Center /ID# 274365, Kettering · a 5 mi di distanza
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
In reclutamentoFase 3
- Miami Valley Hospital South, Centerville · a 9 mi di distanza
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
In reclutamentoFase 3
- Miami Valley Hospital South, Dayton
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
In reclutamentoFase 3
- Miami Valley Hospital South, Centerville · a 9 mi di distanza
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
In reclutamentoFase 3
- Kettering Health, Kettering · a 5 mi di distanza
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
In reclutamento
- Miami Valley Hospital, Dayton
- Miami Valley Hospital North, Dayton
- Miami Valley Hospital South, Centerville · a 9 mi di distanza
- e altri 2
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
In reclutamentoFase 2
- 304, Centerville · a 9 mi di distanza
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
In reclutamentoFase 3
- Miami Valley Hospital South, Centerville · a 9 mi di distanza
Studi su Cancro ovarico in altre città
- Houston, TX89 studi
- New York City, NY69 studi
- Boston, MA61 studi
- Los Angeles, CA50 studi
- Nashville, TN49 studi
- Arlington, VA46 studi
- Philadelphia, PA44 studi
- Columbus, OH39 studi
- St. Louis, MO38 studi
- Chicago, IL36 studi
- San Antonio, TX31 studi
- Cleveland, OH30 studi
Altri studi a Dayton
- Cancro ai polmoni14 studi
- Cancro del polmone non a piccole cellule13 studi
- Malattia epatica steatosica8 studi
- Insufficienza cardiaca8 studi
- Cancro dell'endometrio7 studi
- Cancro alla prostata7 studi
- Cancro (tutti i tipi)7 studi
- Melanoma7 studi
- Obesità7 studi
- Cancro al seno7 studi
- Colite ulcerosa6 studi
- Sovrappeso6 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.